Concurrent Investment Advisors LLC Increases Stock Position in MetLife, Inc. $MET

Concurrent Investment Advisors LLC grew its position in MetLife, Inc. (NYSE:MET) by 20.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,494 shares of the financial services provider’s stock after purchasing an additional 9,005 shares during the period. Concurrent Investment Advisors LLC’s holdings in MetLife were worth $4,144,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brighton Jones LLC increased its holdings in MetLife by 9.0% during the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock worth $347,000 after buying an additional 351 shares during the last quarter. Caxton Associates LLP purchased a new stake in MetLife during the first quarter worth about $307,000. Empowered Funds LLC increased its holdings in MetLife by 187.6% during the first quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock worth $2,680,000 after buying an additional 21,771 shares during the last quarter. Sivia Capital Partners LLC purchased a new stake in MetLife during the second quarter worth about $404,000. Finally, Jump Financial LLC purchased a new stake in MetLife during the second quarter worth about $444,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

MET opened at $77.69 on Tuesday. The company has a market capitalization of $50.65 billion, a price-to-earnings ratio of 16.53, a PEG ratio of 0.69 and a beta of 0.74. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The firm has a 50-day moving average price of $73.11 and a 200-day moving average price of $76.57. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $83.85.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, topping the consensus estimate of $2.34 by $0.15. The firm had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company’s revenue was up 27.6% on a year-over-year basis. During the same quarter last year, the company earned $2.08 earnings per share. Equities analysts expect that MetLife, Inc. will post 9.85 EPS for the current year.

Analyst Upgrades and Downgrades

MET has been the subject of a number of research analyst reports. TD Cowen decreased their price objective on shares of MetLife from $91.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, March 11th. Evercore set a $96.00 price objective on shares of MetLife in a report on Thursday, April 9th. Wall Street Zen upgraded shares of MetLife from a “hold” rating to a “buy” rating in a report on Saturday, April 11th. UBS Group raised their price objective on shares of MetLife from $98.00 to $102.00 and gave the stock a “buy” rating in a report on Thursday, April 9th. Finally, Morgan Stanley decreased their price objective on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $93.38.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.